DMII · Drugs Made In America Acquisition II Corp. · Analyst Estimates
$10.16
-0.01 (-0.07%)
At close · Sep 11
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“management has determined that these conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the financial statements are issued. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.”View the 10-Q filed Aug 14, 2026
Market Cap
$647.37M
Shares
63.70M
Analyst Estimates
Compare analyst forecasts for Drugs Made In America Acquisition II Corp. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Only independently verified consensus published through the company's investor-relations sources is available.
Consensus not yet available
Only independently verified consensus published through the company's investor-relations sources is available.
Key facts
CIK
2040475
CUSIP
G2851K104
13F (30d)
50 filings
50 filers